Related Experiment Video
Updated: Jan 15, 2026
Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
Published on: March 14, 2020
Stem cell therapy for chronic diffuse liver lesions: main symptoms and causes
Yedil Kurakbayev1, Samat Saparbayev2, Botagoz Turdalieva1
1Kazakhstan Medical University "KSPH", Almaty, Kazakhstan.
Insights
New biotechnological methods, including cell therapy with stem cells, offer promising treatments for chronic liver diseases like fibrosis and cirrhosis. This research analyzes advanced cellular technologies to improve patient survival and liver function.
Area of Science:
- Hepatology
- Biotechnology
- Gastroenterology
Background:
- Chronic liver damage, including fibrosis and cirrhosis, presents a significant challenge in gastroenterology with high socio-economic impact.
- The progressive nature of chronic hepatitis necessitates the development of novel therapeutic strategies to improve patient outcomes.
Purpose of the Study:
- To identify and evaluate emerging biotechnological treatments for diffuse liver diseases.
- To enhance patient survival rates, particularly among the active, working-age population affected by liver conditions.
Main Methods:
- A meta-analysis of existing studies on cellular technologies for liver disease treatment was conducted.
- Theoretical scientific methods including analysis, generalization, questioning, and systematization were employed.
Main Results:
- The study reviewed advancements in cellular therapies, focusing on stem cell mechanisms and transdifferentiation in hepatology.
- Potential risks associated with cell therapy, such as pro-oncogenic effects and increased fibrosis, were examined.
Conclusions:
- Cell therapy utilizing embryonic, mononuclear, and mesenchymal stromal cells represents a cutting-edge field in biotechnology and medicine.
- This therapy holds promise for regulating intercellular interactions, cell death, and fibrogenesis in chronic liver diseases, making it a relevant and forward-looking approach in hepatology.
Introduction:
Chronic liver damage is one of the most important and complex problems in modern gastroenterology. The relevance of studying chronic hepatitis of various aetiologies is associated with its high socio-economic and medical significance due to the steady progressive course, with the development of fibrosis, and then cirrhosis of the liver.
Aim:
The purpose of this study was to search for and analyse new biotechnological methods for the treatment of diffuse liver diseases to improve patient survival, since the main contingent of patients is typically the able-bodied, socially active part of the population.
Material And Methods:
To achieve this goal, general theoretical methods of scientific knowledge were used, such as analysis, generalization, questioning, and systematization.
Results:
The article presents a meta-analysis of the results of studies conducted in the field of cellular technologies by leading scientists in the field of the treatment of liver diseases. The issues of transdifferentiation, the mechanisms of action of stem cells in hepatology, as well as the possible risks of this therapy (pro-oncogenic effect, increased fibrosis), are covered.
Conclusions:
Cell therapy in embryonic, mononuclear, and mesenchymal stromal cells is the most advanced area of modern biotechnology and medicine. Its therapeutic application in chronic liver diseases is base on the possibility of regulating disturbed intercellular interactions in the liver, influencing the mechanisms of cell death (necrosis, apoptosis) and fibrogenesis, which makes this method the most relevant and promising in hepatology.
Related Concept Videos
01:21Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
01:24Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...